secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2023-06-13T23:59:59+00:00
Accession:  0001156039-23-000082
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance Health reaffirms FY2023 adjusted EPS guidance >$32.70
--------------------------------------------------------------

- Net income guidance >$29.50 per share including ~$3.20 net unfavorable items.
- Adjusted net income guidance >$32.70 per share, excluding items from Q1 2023 earnings.
- Company officers to meet with investors over upcoming weeks; reaffirms prior outlook.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000115603923000082/0001156039-23-000082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000115603923000082/elv-20230613.htm
  HTML page:      https://secwatch.observer/filing/0001156039-23-000082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer